The preliminary study focusing on HERV-W Env detection in serum was set up for an evaluation of specificity, after RNA PCR studies had repeatedly confirmed an association with MS.39 Positive Env detection was observed in a large majority of MS patients. The gene discussed is ERVW-1; the disease is myeloid sarcoma.